190 related articles for article (PubMed ID: 18855599)
41. Mesangial cells possess an asialoglycoprotein receptor with affinity for human immunoglobulin A.
Gómez-Guerrero C; Duque N; Egido J
J Am Soc Nephrol; 1998 Apr; 9(4):568-76. PubMed ID: 9555658
[TBL] [Abstract][Full Text] [Related]
42. Surface and internal galactosyl receptors are heterooligomers and retain this structure after ligand internalization or receptor modulation.
Herzig MC; Weigel PH
Biochemistry; 1990 Jul; 29(27):6437-47. PubMed ID: 2169871
[TBL] [Abstract][Full Text] [Related]
43. Effect of chronic ethanol administration on total asialoglycoprotein receptor content and intracellular processing of asialoorosomucoid in isolated rat hepatocytes.
Casey CA; Kragskow SL; Sorrell MF; Tuma DJ
Biochim Biophys Acta; 1990 Apr; 1052(1):1-8. PubMed ID: 2322585
[TBL] [Abstract][Full Text] [Related]
44. The cyanogen bromide fragment I of asialoorosomucoid is transported more efficiently than asialoorosomucoid in rat hepatocytes.
Chang TM; Chakraborti P; Chang CH
Biochim Biophys Acta; 1989 Feb; 1010(2):166-76. PubMed ID: 2912500
[TBL] [Abstract][Full Text] [Related]
45. Interaction of a Triantennary Quinoline Glycoconjugate with the Asialoglycoprotein Receptor.
Palit S; Banerjee S; Mahata T; Niyogi S; Das T; Sova Mandi C; Chakrabarti P; Dutta S
ChemMedChem; 2021 Jul; 16(14):2211-2216. PubMed ID: 33860988
[TBL] [Abstract][Full Text] [Related]
46. Flow cytometric analysis of asialoglycoprotein receptor expression predicts hepatic functional reserve after hepatectomy.
Ke Z; Li J; Zhe J; Liang LB; Yan L; Yi M
J Coll Physicians Surg Pak; 2014 Nov; 24(11):820-4. PubMed ID: 25404440
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of hepatocarcinoma by systemic delivery of Apoptin gene via the hepatic asialoglycoprotein receptor.
Peng DJ; Sun J; Wang YZ; Tian J; Zhang YH; Noteborn MH; Qu S
Cancer Gene Ther; 2007 Jan; 14(1):66-73. PubMed ID: 16874360
[TBL] [Abstract][Full Text] [Related]
48. Interactions of human mesangial cells with IgA and IgA-containing immune complexes.
Novak J; Vu HL; Novak L; Julian BA; Mestecky J; Tomana M
Kidney Int; 2002 Aug; 62(2):465-75. PubMed ID: 12110007
[TBL] [Abstract][Full Text] [Related]
49. The B domain of coagulation factor VIII interacts with the asialoglycoprotein receptor.
Bovenschen N; Rijken DC; Havekes LM; van Vlijmen BJ; Mertens K
J Thromb Haemost; 2005 Jun; 3(6):1257-65. PubMed ID: 15946216
[TBL] [Abstract][Full Text] [Related]
50. Capacity limits of asialoglycoprotein receptor-mediated liver targeting.
Bon C; Hofer T; Bousquet-Mélou A; Davies MR; Krippendorff BF
MAbs; 2017; 9(8):1360-1369. PubMed ID: 28876162
[TBL] [Abstract][Full Text] [Related]
51. Functional size of the human asialoglycoprotein receptor as determined by radiation inactivation.
Schwartz AL; Steer CJ; Kempner ES
J Biol Chem; 1984 Oct; 259(19):12025-9. PubMed ID: 6090451
[TBL] [Abstract][Full Text] [Related]
52. Effects of hyperosmolarity on ligand processing and receptor recycling in the hepatic galactosyl receptor system.
Oka JA; Weigel PH
J Cell Biochem; 1988 Feb; 36(2):169-83. PubMed ID: 2833526
[TBL] [Abstract][Full Text] [Related]
53. Iron loading of isolated rat hepatocytes inhibits asialoglycoprotein receptor dynamics and induces formation of rat hepatic lectin-1 [correction of leptin-1] (RHL-1) oligomers.
McAbee DD; Ling YY; Stich C
Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):719-26. PubMed ID: 9560297
[TBL] [Abstract][Full Text] [Related]
54. Second messenger modulation of the asialoglycoprotein receptor.
Stockert RJ; Morell AG
J Biol Chem; 1990 Feb; 265(4):1841-6. PubMed ID: 2153666
[TBL] [Abstract][Full Text] [Related]
55. Study on the variables affecting toxicity of hybrid toxins. The effect of different target cell receptor distribution and toxin binding chain.
Chang TM; Chang CH
Biochim Biophys Acta; 1989 Oct; 1013(3):239-46. PubMed ID: 2804085
[TBL] [Abstract][Full Text] [Related]
56. Hepatic disposition of cationic drugs bound to asialoorosomucoid: lack of coendocytosis and evidence for intrahepatic dissociation.
van der Sluijs P; Spanjer HH; Meijer DK
J Pharmacol Exp Ther; 1987 Feb; 240(2):668-73. PubMed ID: 3806418
[TBL] [Abstract][Full Text] [Related]
57. Hepatocyte-targeting gene delivery using a lipoplex composed of galactose-modified aromatic lipid synthesized with click chemistry.
Sakashita M; Mochizuki S; Sakurai K
Bioorg Med Chem; 2014 Oct; 22(19):5212-9. PubMed ID: 25155912
[TBL] [Abstract][Full Text] [Related]
58. Hepatic asialoglycoprotein receptor-mediated binding of human polymeric immunoglobulin A.
Daniels CK; Schmucker DL; Jones AL
Hepatology; 1989 Feb; 9(2):229-34. PubMed ID: 2912827
[TBL] [Abstract][Full Text] [Related]
59. Construction and characterization of an anti-asialoglycoprotein receptor single-chain variable-fragment-targeted melittin.
Zhao X; Yu Z; Dai W; Yao Z; Zhou W; Zhou W; Zhou J; Yang Y; Zhu Y; Chen S; Cao L
Biotechnol Appl Biochem; 2011; 58(6):405-11. PubMed ID: 22172103
[TBL] [Abstract][Full Text] [Related]
60. New Small-Molecule Glycoconjugates of Docetaxel and GalNAc for Targeted Delivery to Hepatocellular Carcinoma.
Petrov RA; Mefedova SR; Yamansarov EY; Maklakova SY; Grishin DA; Lopatukhina EV; Burenina OY; Lopukhov AV; Kovalev SV; Timchenko YV; Ondar EE; Ivanenkov YA; Evteev SA; Vaneev AN; Timoshenko RV; Klyachko NL; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
Mol Pharm; 2021 Jan; 18(1):461-468. PubMed ID: 33264010
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
